Literature DB >> 25602793

Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.

Nicole C Panarelli1, Cecily P Vaughn, Wade S Samowitz, Rhonda K Yantiss.   

Abstract

Most sporadic colonic adenocarcinomas are microsatellite stable (MSS) and arise from conventional adenomas by dysregulation of the APC/β-catenin/Wnt signaling pathway. Sporadic adenocarcinomas with a high degree of microsatellite instability (MSI) likely arise from sessile serrated polyps through the serrated neoplastic pathway. These polyps contain BRAF mutations and are prone to epigenetic methylation that ultimately silences MLH1, leading to MSI and heralding progression of dysplasia to invasive adenocarcinoma. Most investigators believe that these 2 models of cancer progression are mutually exclusive, although recent studies describe Wnt signaling activation in serrated polyps and propose that it plays a role in the development of sporadic colonic adenocarcinomas with MSI. We sought to test this hypothesis by evaluating β-catenin immunoexpression in 44 sporadic microsatellite unstable adenocarcinomas and 44 MSS colon cancers. We defined sporadic MSI-high carcinomas as those with loss of MLH1 and PMS2 immunostaining and BRAF V600E mutations that occurred in patients 50 years of age or older without a family history of colonic adenocarcinoma or Lynch syndrome. Forty-one (93%) of these carcinomas displayed membranous β-catenin staining only, compared with 28 (64%) site-matched MSS tumors with abnormal nuclear β-catenin staining.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25602793     DOI: 10.1097/PAS.0000000000000380

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

1.  Small bowel carcinomas in celiac or Crohn's disease: distinctive histophenotypic, molecular and histogenetic patterns.

Authors:  Alessandro Vanoli; Antonio Di Sabatino; Michele Martino; Catherine Klersy; Federica Grillo; Claudia Mescoli; Gabriella Nesi; Umberto Volta; Daniele Fornino; Ombretta Luinetti; Paolo Fociani; Vincenzo Villanacci; Francesco P D'Armiento; Renato Cannizzaro; Giovanni Latella; Carolina Ciacci; Livia Biancone; Marco Paulli; Fausto Sessa; Massimo Rugge; Roberto Fiocca; Gino R Corazza; Enrico Solcia
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

2.  MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.

Authors:  Kosuke Mima; Reiko Nishihara; Juhong Yang; Ruoxu Dou; Yohei Masugi; Yan Shi; Annacarolina da Silva; Yin Cao; Mingyang Song; Jonathan Nowak; Mancang Gu; Wanwan Li; Teppei Morikawa; Xuehong Zhang; Kana Wu; Hideo Baba; Edward L Giovannucci; Jeffrey A Meyerhardt; Andrew T Chan; Charles S Fuchs; Zhi Rong Qian; Shuji Ogino
Journal:  Clin Cancer Res       Date:  2016-03-08       Impact factor: 12.531

Review 3.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

4.  Reliable Detection of Mismatch Repair Deficiency in Colorectal Cancers Using Mutational Load in Next-Generation Sequencing Panels.

Authors:  Zsofia K Stadler; Francesca Battaglin; Sumit Middha; Jaclyn F Hechtman; Christina Tran; Andrea Cercek; Rona Yaeger; Neil H Segal; Anna M Varghese; Diane L Reidy-Lagunes; Nancy E Kemeny; Erin E Salo-Mullen; Asad Ashraf; Martin R Weiser; Julio Garcia-Aguilar; Mark E Robson; Kenneth Offit; Maria E Arcila; Michael F Berger; Jinru Shia; David B Solit; Leonard B Saltz
Journal:  J Clin Oncol       Date:  2016-03-28       Impact factor: 44.544

5.  Targeted Therapy in Metastatic Colorectal Cancer: Current Standards and Novel Agents in Review.

Authors:  Rebecca A DeStefanis; Jeremy D Kratz; Philip B Emmerich; Dustin A Deming
Journal:  Curr Colorectal Cancer Rep       Date:  2019-03-20

Review 6.  Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?

Authors:  François Ghiringhelli; Jean-David Fumet
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

Review 7.  Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Authors:  Jeroen M Bugter; Nicola Fenderico; Madelon M Maurice
Journal:  Nat Rev Cancer       Date:  2020-10-23       Impact factor: 60.716

8.  Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.

Authors:  Jung Ho Kim; Jeong Mo Bae; Nam-Yun Cho; Gyeong Hoon Kang
Journal:  Oncotarget       Date:  2016-03-22

9.  Early diagnostic potential of APC hypermethylation in esophageal cancer.

Authors:  Bujiang Wang; Haojun Song; Haizhong Jiang; Yangbo Fu; Xiaoyun Ding; Chongchang Zhou
Journal:  Cancer Manag Res       Date:  2018-02-01       Impact factor: 3.989

Review 10.  APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review.

Authors:  Tie-Jun Liang; Hong-Xu Wang; Yan-Yan Zheng; Ying-Qing Cao; Xiaoyu Wu; Xin Zhou; Shu-Xiao Dong
Journal:  Oncotarget       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.